Please login to the form below

Not currently logged in
Email:
Password:

Advaxis

This page shows the latest Advaxis news and features for those working in and with pharma, biotech and healthcare.

Daily Brief: Immunotherapy firm Advaxis cuts back, Pfizer wins price gouging appeal

Daily Brief: Immunotherapy firm Advaxis cuts back, Pfizer wins price gouging appeal

BIOTECH. Immunotherapy-focused Advaxis forced to scale back. Billions of dollars of investment is flooding into immunotherapy-based R&D, but some overstretched biotechs are having to scale back on ambitious ... goals. Once such company is Advaxis, which

Latest news

More from news
Approximately 5 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Acquisition - company. 705. Advaxis/ SELLAS Life Sciences Group. Advaxis' Lm-based antigen delivery technology with SELLAS’WT1 targeted heteroclitic peptide antigen mixture (galinpepimut-S) (pre-clinical).

  • Deal Watch August 2016 Deal Watch August 2016

    624. Advaxis (US). Amgen (US). Licence. ADXS-NEO, preclinical investigational cancer immunotherapy treatment.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics